HOUSTON, TX, June 18, 2018 (GLOBE NEWSWIRE) — AngioSoma, Inc. (SOAN) is excited to announce that we have identified a regulatory firm who can assist taking our patented flagship drug, Liprostin™, through the FDA approval process.  The regulatory firm will begin with a presubmission meeting with the FDA biologic group to obtain a regulatory strategy […]